Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 5Completed 2Terminated 1

Sponsor Class

UNKNOWN 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Breast Neoplasms 334Carcinoma, Non-Small-Cell Lung 262Ovarian Neoplasms 177Lung Neoplasms 129Neoplasms 92Fallopian Tube Neoplasms 77Carcinoma, Ovarian Epithelial 63Neoplasm Metastasis 59Esophageal Neoplasms 58Stomach Neoplasms 49Head and Neck Neoplasms 45Squamous Cell Carcinoma of Head and Neck 44Triple Negative Breast Neoplasms 40Endometrial Neoplasms 37Adenocarcinoma of Lung 32Urinary Bladder Neoplasms 28Esophageal Squamous Cell Carcinoma 26Unspecified Adult Solid Tumor, Protocol Specific 24Uterine Cervical Neoplasms 23Carcinoma 23Melanoma 22Breast Neoplasms, Male 22Small Cell Lung Carcinoma 20Prostatic Neoplasms 20Parkinson Disease 4, Autosomal Dominant Lewy Body 20Adenocarcinoma Of Esophagus 20Recurrence 19Brenner Tumor 18Adenocarcinoma, Bronchiolo-Alveolar 18Peritoneal Neoplasms 16

Interventions

Cisplatin 15Gemcitabine 7Fluorouracil 6Docetaxel 6Radiotherapy, Intensity-Modulated 5Oxaliplatin 4Capecitabine 4pembrolizumab 3Radiotherapy 3Carboplatin 3Acupuncture Therapy 3Psychiatric Rehabilitation 2Paclitaxel 2Nicotine 2Counseling 2Cetuximab 2Celecoxib 2Bupropion 2tislelizumab 1spartalizumab 1sargramostim 1motexafin gadolinium 1fosaprepitant 1fialuridine 1endostar protein 1cc-486 1apatinib 1Zoledronic Acid 1Zinc Oxide 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Nasopharyngeal Neoplasms × Paclitaxel × Clear all
NCT00003206 2023-06-15

Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
Head & Neck

Head and Neck Neoplasms, Nasopharyngeal Neoplasms

NCT01797900 2014-09-10

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

ChineseAMS

Phase 2 Completed
130 enrolled
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡